{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:14:48Z","timestamp":1789989288654,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.toxicon.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T11:20:30Z","timestamp":1379589630000},"page":"394-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Is scorpion antivenom cost-effective as marketed in the United States?"],"prefix":"10.1016","volume":"76","author":[{"given":"Edward P.","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Bakall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant H.","family":"Skrepnek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie V.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.toxicon.2013.09.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nbt.2482","article-title":"Failure to launch: a slew of disappointing product launches suggests biotech companies are ill prepared to navigate an increasingly parsimonious reimbursement environment","volume":"31","author":"Anonymous","year":"2013","journal-title":"Ed. Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2013.09.001_bib2","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1056\/NEJMoa0808455","article-title":"Antivenom for critically ill children with neurotoxicity from scorpion stings","volume":"360","author":"Boyer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.toxicon.2013.09.001_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.toxicon.2012.12.015","article-title":"History of antivenom: one Arizonan's view","volume":"69","author":"Boyer","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.09.001_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.toxicon.2013.07.014","article-title":"Effectiveness of Centruroides scorpion antivenom compared to historical controls","volume":"76","author":"Boyer","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.09.001_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.toxicon.2013.07.017","article-title":"Safety of intravenous equine F(ab')2: Insights following clinical trials involving 1534 recipients of scorpion antivenom","volume":"76","author":"Boyer","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2013.09.001_bib6","series-title":"10 Top Drug Launch Disasters: Payer Risk Looms Large as Biopharma Marketing Snafus Highlight Industry's Achilles' Heel","author":"Carroll","year":"2012"},{"key":"10.1016\/j.toxicon.2013.09.001_bib7","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.CCM.0000164543.14619.00","article-title":"Daily cost of an intensive care unit day: the contribution of mechanical ventilation","volume":"33","author":"Dasta","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.toxicon.2013.09.001_bib8","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.toxicon.2013.09.001_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s13181-012-0233-3","article-title":"Clinical course of bark scorpion envenomation managed without antivenom","volume":"8","author":"O'Connor","year":"2012","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.toxicon.2013.09.001_bib10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.annemergmed.2005.11.042","article-title":"Lack of scorpion antivenom leads to increased pediatric ICU admissions","volume":"47","author":"Riley","year":"2006","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2013.09.001_bib11","series-title":"Principles of Pharmacoeconomics","first-page":"83","article-title":"Cost-effectiveness analysis","author":"Skrepnek","year":"2005"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113003516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010113003516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T19:55:45Z","timestamp":1539374145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010113003516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":11,"alternative-id":["S0041010113003516"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.09.001","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is scorpion antivenom cost-effective as marketed in the United States?","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}